Institution
Vall d'Hebron Institute of Oncology
Also known as: Vall d’Hebron Institut d’Oncologia · VHIO · VHIO-CERCA
- 55running trials
- 28closed trials
- 8,715publications (OpenAlex)
Running trials
Recruiting
Fight Osteosarcoma Through European Research Evolving Study Platform From Diagnosis to Relapse
Not yet recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Not yet recruiting
Recruiting
Recruiting
Phase 1/2 Study to Evaluate TH9619 in the Treatment of Advanced Solid Tumors
Recruiting
Recruiting
A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors
Recruiting
Recruiting
Active, not recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Active, not recruiting
Active, not recruiting
T-DXd Therapy for HER2-low Breast Cancer Patients With Brain Metastases
Recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Recruiting
Recruiting
A Study to Evaluate the Safety and Tolerability of TOS-358 in Women With HR+ HER2- Breast Cancer
Recruiting
Recruiting
Recruiting
Dose-finding and Dose Expansion Study of OSE-279 in Subjects With Advanced Solid Tumors or Lymphomas
Active, not recruiting
Recruiting
Recruiting
Recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Phase 3 Study of Pelabresib (CPI-0610) in Myelofibrosis (MF) (MANIFEST-2)
Recruiting
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
Recruiting
A Retrospective Protocol Empowering Precision Research in Colorectal Cancer (ALFAOMEGA-RETRÒ)
Recruiting
Active, not recruiting
Study BT8009-100 in Subjects With Nectin-4 Expressing Advanced Malignancies
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting
Recruiting
Multivirus-specific T-cell Transfer Post SCT vs AdV, CMV and EBV Infections
Active, not recruiting
Showing 50 of 55.
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Lung cancer10 recruiting
- Colorectal cancer9 recruiting
- Endometrial cancer5 recruiting
- Head and neck cancer5 recruiting
- Metastatic breast cancer5 recruiting
- Gastric and oesophageal cancer4 recruiting
- Pancreatic cancer4 recruiting
- Bladder cancer3 recruiting
- Cervical cancer3 recruiting
- Childhood cancers3 recruiting
- Glioblastoma2 recruiting
- Kidney cancer2 recruiting
- Liver and biliary tract cancer2 recruiting
- Melanoma2 recruiting
- Ovarian cancer2 recruiting
- Acute lymphoblastic leukaemia1 recruiting
- Chronic lymphocytic leukaemia1 recruiting
- Cytomegalovirus infection1 recruiting
- Multiple myeloma1 recruiting
- Myelodysplastic syndromes1 recruiting
- Sarcoma1 recruiting
- Triple-negative breast cancer1 recruiting
Closed trials
Completed
Completed
Completed
HER3-DXd in Breast Cancer and NSCLC Brain Metastases and Solid Tumor Leptomeningeal Disease
Completed
Terminated
Completed
Completed
Completed
Terminated
Completed
A Study of CM24 in Combination with Nivolumab in Adults with Advanced Solid Tumors
Completed
Completed
Terminated
Completed
Completed
Completed
Terminated
A Study of ZEN003694 and Talazoparib in Patients With Triple Negative Breast Cancer
Terminated
Completed
Advanced GC Multi-omic Characterization in EU and CELAC Populations
Terminated
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
A Phase 1 Study of Fisogatinib (BLU-554) in Patients With Hepatocellular Carcinoma
Registry name variants (10)
Trial registries list this institution under these names. Each row is one registry entry: its address and the trials registered under it.
Vall d'Hebron Institute of Oncology
Barcelona, 08035
46 trials
Vall d?Hebron Institute of Oncology (VHIO), Barcelona
Barcelona, 08035
16 trials
Vall d'Hebron Institute of Oncology (VHIO)
Barcelona, 08035
10 trials
Vall d'Hebron Institut d'Oncologia
Barcelona, 8035
4 trials
Vall d'Hebron Institut d'Oncologia (VHIO)
Barcelona, 08035
2 trials
NCT05303519SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
Contact: VHIO Clinical Trials Office
Vall d'Hebron Instituto de Oncologia
Barcelona, Barcelona 08035
2 trials
NCT07020221A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors
Contact: Elena Garralda, MD
Contact: Relay Therapeutics Inc
Vall d'Hebron Institute of Oncology (VHIO), Barcelona
Sant Andreu de la Barca, Barcelona 08740
1 trial
Vall d'Hebron Institute of Oncology (VIHO)
Barcelona, 08035
1 trial
NCT04657068A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
Contact: Sarah Cannon Development Innovations
Vall d'Hebron Instituto de Oncología (VHIO)
Barcelona
1 trial
Data review: Vall d'Hebron institute of Oncology (VHIO).
Barcelona, 08035
Conditions
Diseases this institution publishes on or runs trials for.
- Lung cancer101 works · 25 trials
- Colorectal cancer73 works · 18 trials
- Metastatic breast cancer43 works · 9 trials
- Melanoma38 works · 10 trials
- Kidney cancer33 works · 7 trials
- Brain metastases20 works · 2 trials
- Neuroendocrine tumours19 works · 3 trials
- Myeloproliferative neoplasms10 works · 1 trial
- Chronic lymphocytic leukaemia10 works · 1 trial
- Myelodysplastic syndromes9 works · 1 trial
Institution data: ROR 054xx3904 (CC0-1.0)Updated 15 Nov 2026